Literature DB >> 6957194

Interrelationships of HLA-DR, MB, and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus.

J M Ahearn, T T Provost, C A Dorsch, M B Stevens, W B Bias, F C Arnett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6957194     DOI： 10.1002/art.1780250901

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  32 in total

Review 1.  Systemic lupus erythematosus: RNA-protein autoantigens, models of disease heterogeneity, and theories of etiology.

Authors:  J B Harley; R H Scofield
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

2.  HLA class II restriction of autoantibody production in patients with systemic lupus erythematosus.

Authors:  H A Stephens; N J McHugh; P J Maddison; D A Isenberg; K I Welsh; G S Panayi
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  The genetic basis of Ro and La antibody formation in systemic lupus erythematosus. Results of a multicenter study. The SLE Study Group.

Authors:  K Hartung; H Ehrfeld; H J Lakomek; R Coldewey; B Lang; F Krapf; R Müller; D Schendel; H Deicher; H P Seelig
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

4.  HLA class II phenotype controls diversification of the autoantibody response in primary Sjögren's syndrome (pSS).

Authors:  M Rischmueller; S Lester; Z Chen; G Champion; R Van Den Berg; R Beer; T Coates; J McCluskey; T Gordon
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

Review 5.  Passively acquired autoimmunity and the maternal fetal dyad in systemic lupus erythematosus.

Authors:  J Buyon; I Szer
Journal:  Springer Semin Immunopathol       Date:  1986

Review 6.  Systemic lupus erythematosus clinical issues.

Authors:  M B Stevens
Journal:  Springer Semin Immunopathol       Date:  1986

7.  Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant.

Authors:  F C Arnett; M L Olsen; K L Anderson; J D Reveille
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

8.  Differences in HLA antigens between patients with mixed connective tissue disease and systemic lupus erythematosus.

Authors:  P Ruuska; R Hämeenkorpi; S Forsberg; H Julkunen; R Mäkitalo; J Ilonen; A Tiilikainen
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

9.  Antibodies to nRNP, Sm, Ro(SSA) and La(SSB) detected by ELISA: their specificity and inter-relations in connective tissue disease sera.

Authors:  P J Maddison; R P Skinner; P Vlachoyiannopoulos; D M Brennand; D Hough
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

10.  No direct correlation between HLA-DPB1 and antibodies against recombinant Ro (SS-A)/La (SS-B) proteins in systemic lupus erythematosus. SLE Study Group.

Authors:  Z Yao; K Hartung; H Ehrfeld; H P Seelig; H G Deicher; G Brünnler; E Keller; E Albert
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.